Learn more

AUTOTELIC BIO INC

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    122,618
About

AUTOTELIC BIO INC has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Brazil. Its main competitors in its focus markets pharmaceuticals and measurement are HAL ALLERGY HOLDING B V, PHARNEXT and ANDRX LABS LLC.

Patent filings in countries

World map showing AUTOTELIC BIO INCs patent filings in countries
# Country Total Patents
#1 Republic of Korea 6
#2 WIPO (World Intellectual Property Organization) 5
#3 Brazil 1
#4 China 1
#5 United States 1

Patent filings per year

Chart showing AUTOTELIC BIO INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Measurement

Top inventors

# Name Total Patents
#1 Kim Tae Hun 11
#2 Park Jun Eui 8
#3 Choi Jae Cheol 3
#4 Oh Dong Won 3
#5 Kim Ji Hye 2
#6 Lee Hee Pom 2
#7 Hong Jin Tae 2
#8 Kim Ji-Hye 2
#9 Kim Tae-Hun 2
#10 Lee Jeong Min 2

Latest patents

Publication Filing date Title
WO2020149712A1 Cancer treatment composition
KR20200033209A A composition for treating cancer
KR20200031029A Composition for treating or preventing cancer comprising 2-(3-[2-(1-Cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2- quinazolinylsulfanyl)-N-(4-ethylphenyl)butanamide as an active ingredient
WO2020054981A1 Composition for treating or preventing cancer comprising 2-(3-[2-(1-cyclohexen-1-yl)ethyl]-6,7-dimethoxy-4-oxo-3,4-dihydro-2-quinazolinylsulfanyl)-n-(4-ethylphenyl)butanamide as active ingredient
KR20200048516A A pharmaceutical composition of combination
KR20200028796A A pharmaceutical composition with an improved stability
KR101943382B1 A pharmaceutical composition comprising SGLT-2 inhibitor and angiotensin receptor blocker